INTRODUCTION
Prion diseases are characterised by accumulation of infectious particles of protease-resistant prion (PrPres) (Prusiner et al., 1982) . This pathological isoform results from modification of normal cellular protein called PrPc. This protein is widely distributed in the brain and other organs notably in the lymphoreticular system.
The symptoms of prion diseases always occur after accumulation of PrPres in the nervous system, leading to observable pathological lesions. After peripheral infection, however, PrPres is detected during the pre-clinical stages in the spleen and other lymphoid organs. Abundant PrPres was recently detected, before the appearance of the clinical signs of the disease, in the germinal centres of tonsils (Hill et al., 1997) and appendixes (Hilton et al., 1998 ) from patients affected with nvCJD.
The prion diseases are now widely studied in experimental models. Inoculation of PrPres into wild-type mice induces the different symptoms, whereas injection into PrP-deficient mice leads neither death nor to infectivity. This demonstrates the major role played by PrPc (Bueler et al., 1993) .
Results obtained with immunodeficient mouse models show that lymphoid organs are involved in various steps of disease development after peripheral inoculation (Cesbron et al., 1998; Aucouturier et al., 1999) . It is not clear, however, which immune system : I I:: cells play a key role in pathogenicity. Spleen fractionation studies have shown that infectivity is associated with the stromal fraction and with lymphocytes (Clarke and Kimberlin, 1984; Raeber et al., 1999) . The incubation period in peripherally infected mice is unaffected by whole body irradiation (Fraser and Farquhar, 1987) . Thus, the prion replication depends on PrPc and notably on a radiation-resistant fraction of the cell population of lymphoid tissues. Follicular dendritic cells (FDC) belong to this radio-resistant fraction and are stromal cells (Kinet-Deno61 et al., 1982) . SCID mice lacking functional B and T cells and also functional FDC are resistant to peripheral infection by scrapie agent but develop the disease after a bone marrow reconstitution (Fraser et al., 1996) . Reconstitution restores the presence of mature T and B cells and induces differentiation of functional follicular dendritic cells (Kapasi et al., 1993) .
Immunohistochemical staining with anti-PrP antibodies reveals an extraordinary accumulation of PrPres in the lymphoid follicles, especially in the form of a delicate network (Kitamoto et al., 1991; McBride et al., 1992; Klein et al., 1998; Jeffrey et al., 1999 extensions was intensely labelled (Fig. 1) . After anti-PrP immunolabelling of cryosections with 3F4 antibody, the keratinocytes lining the crypts mainly at the level of basal cells were stained densely as it was previously reported by Pammer (Pammer et al., 1998) , however, the germinal centres displayed a very low labelling. In the germinal centres, fine peroxidase reagent deposits were found along the intercellular spaces of the constituent cells (Fig. 2 A-B (Fig. 4 A-B) .
The percentage and intensity of positive FDC-clusters depended to some degree on the monoclonal antibody used; 12F10 and 3F4 were recommended. (Fig. 6 A-B) . PrPc was detected with both antibodies and labelling was intense as with Jurkat cells (Fig. 7) . 
DISCUSSION

MATERIALS AND METHODS
Isolation and Purification of FDC-clusters
Palatine tonsils were surgically removed from children aged 3 to 10. FDC-clusters were isolated by two different procedures, enzymatically for culturing and non-enzymatically for immunostaining on cytospins.
Enzymatic digestion method was described elsewhere (Tsunoda et al., 1990) ; the tonsils were cut in slices (1 mm thick) and digested for 20 min at 37C with an enzyme cocktail containing 0.1% collagenase (Type A, Boehringer-Mannheim), For immunohistochemistry, some FDC-clusters were cultured on polylysine-coated glass coverslips in 6-well culture plates.
Immunohistochemistry
Cryosections (8-10 m) of tonsils and cytospins of FDC-clusters (non-enzymatically isolated) were fixed in acetone for 10 min at 4C. On the other hand, FDC cultured on polylysine-coated glass coverslips for 4 days were fixed in paraformaldehyde 2 % for 10 min at 4C.
Cryosections and cytospecimens were treated with a non-specific rabbit serum for 15 min, then allowed to react for 1 h at room temperature with MoAbs: DRC1 (Dako, Denmark), 12F10, 3B5, 8G8 or 3F4 antibody at optimal dilution (1/100, 1/100, 1/100, 1/100 and 1/200 respectively). The Negative controls consisted of preparations in which the specific antibody was replaced with non-specific mouse serum and once from which the primary antibody was omitted.
Flow-cytometric Analysis
After 6 days of culture, the FDC were checked for the ability to effect B lymphocytes emperipolesis. This is a reliable test for identifying FDC in vitro (Tsunoda et al., 1992) . Freshly prepared tonsillar B lymphocytes were added to the monolayered FDC in vitro. Cultured FDC can entrap lymphocytes beneath their cytoplasm extensions (pscudoemperipolesis). Other FDC that had been cultured for 6 days were harvested by treatment with 0.25 % trypsin and 0.04 % ethylenediamine tetra-acetic acid in PBS and washed. Some detached FDC were stored in FCS on ice until immunostaining. Others were cultured for 15 h at 37C as cell suspensions in R_PMI containing 10 % FCS and HEPES. This was done with the Techne(R) system (Duxford Cambridge, UK) avoiding attachment to the substrate. Thereafter, the cells were collected and washed. Both types of FDC preparation were incubated with biotinylated monoclonal antibody (8G8 or 3B5), followed by Streptavidin-Per-Cys (Dako, Denmark). Jurkat cells (human T-cell lymphoma-cell line) constituted the positive control for PrPc. In the negative control, we used non-specific murine IgG-Per-Cys (Dako, Denmark).
The fluorescence intensity was analyzed by means of the Cell-Quest system with a FACScan flow cytometer (Becton-Dickinson, USA).
